10x Insights
Loading account…
Companies / Healthcare / Owlet, Inc.
OWLT

Owlet, Inc.

HealthcareMedical Instruments
Ticker OWLTLEHI, UTFiscal year ends DecemberBook value per share $0.82Diluted shares 28.1M

Owlet, Inc. (NASDAQ: OWLT) operates as a leading pediatric health platform delivering hospital-grade monitoring technology through consumer-friendly interfaces. The company's website is www.owlet.com. Founded in 2012, Owlet has sold over 2.5 million devices globally and operates one of the largest proprietary datasets… From the company’s description.

Fiscal year 2025 · ends 12-31Changes are against fiscal 2024The amber dot is the latest twelve months, to 2026-06-30
Sales & profitability
$105.71M
+35.4% year over year
Last 12 mo $114.86M
-7.81%
+18.1 percentage points
Last 12 mo -6.38%
$-39.68M
−216.5% year over year
Last 12 mo $-8.92M
-208.37%
−250.5 percentage points
Last 12 mo -38.56%
Cash & financing
$-10.79M
+3.7% year over year
Last 12 mo $-7.76M
$-11.62M
+2.2% year over year
Last 12 mo $-9.69M
0.68
Was -0.39× a year earlier
Last 12 mo 0.74
18.1M
+65.2% year over year
Last 12 mo 28.1M

Margins and return on equity change in ; everything else in percent. Fewer shares and less debt are shown plainly, not as bad news — it depends what you make of buybacks. Dotted labels explain each measure. is shown separately from the annual figures.

What Owlet, Inc. does

In the company’s own words

Owlet, Inc. (NASDAQ: OWLT) operates as a leading pediatric health platform delivering hospital-grade monitoring technology through consumer-friendly interfaces. The company's website is www.owlet.com. Founded in 2012, Owlet has sold over 2.5 million devices globally and operates one of the largest proprietary datasets of infant health and sleep information.

The company's core business centers on medically certified wearable monitors and integrated software services designed to bridge the gap between clinical care and home monitoring. Owlet's primary product, Dream Sock, is an FDA-cleared wearable infant health monitor equipped with pulse oximetry technology that tracks vital signs including pulse rate, oxygen level, activity, and sleep patterns. The device delivers real-time notifications when readings fall outside preset ranges and provides tailored sleep insights through the Owlet Dream App. Dream Sock has received regulatory clearances in multiple international markets including the European Union, United Kingdom, Australia, South Africa, India, and Israel.

BabySat represents Owlet's prescription-based offering, an FDA-cleared pulse oximeter designed for infants with diagnosed conditions such as RSV, pneumonia, and bronchitis. This product enables insurance reimbursement pathways and has expanded Owlet's presence in healthcare distribution channels. Dream Sight, the company's smart audio and video monitor, features 2K HD video, motion and cry detection, and two-way audio capabilities. Dream Duo combines Dream Sock and Dream Sight into an integrated health and safety system.

Owlet360, launched in January 2025, represents the company's subscription service leveraging pediatric health data to provide personalized insights on child development, health, and sleep trends. The service is available in English-speaking markets including the United States, United Kingdom, Ireland, South Africa, Australia, and New Zealand.

The company distributes products through direct-to-consumer channels, major U.S. retailers including Amazon, Target, Walmart, and Best Buy, and increasingly through healthcare distribution partnerships. Owlet operates globally, selling products in over 30 countries. The company generated approximately $105.7 million in revenue during 2025, representing a significant scale milestone for the pediatric health monitoring sector.

Company details
Sector
Healthcare
Industry
Medical Instruments
Headquarters
LEHI, UT
Fiscal year end
December
CIK
1816708
SIC
3829

Financial performance, year by year

Fiscal 2020–2025 · USD
$-98.76M$-40.50M$17.76M$76.02M$134.28M202020212022202320242025Last 12 moLast 12 monthsLast 12 months

The full income statement, balance sheet and cash flow for each of these years — every figure traceable to its filing — is on the Financials tab with a free account.

Ownership

Who owns Owlet, Inc. — and what changed

Funds as of 2026Q2 · superinvestors as of 2026-06-30

24
funds hold it
0 of 35
superinvestors hold it
$12.32M
held by funds, at market
7.6%
of shares held by funds

Largest fund holders · Owlet, Inc.’s weight in each

0.13%of fund net assets
VANGUARD TOTAL STOCK MARKET INDEX FUND
VTI · VANGUARD INDEX FUNDS
0.00%of fund net assets
VANGUARD EXTENDED MARKET INDEX FUND
VXF · VANGUARD INDEX FUNDS
0.00%of fund net assets
Embark Small Cap Equity Fund
ESCQX · Harbor Funds II
0.20%of fund net assets
Victory Small Cap Stock Fund
USCAX · Victory Portfolios III
0.09%of fund net assets

Fund ownership is a floor, not a census — pensions, insurers and people holding shares directly are not visible here.

Fund ownership counts N-PORT filers only, so it is a floor rather than a census — pensions, insurers and direct holders are not visible here, and the remainder is not “held by individuals”.

Could not be determined for this company: bond issues.

Every fund and institutional holder, quarter by quarter, is on the Ownership tab with a free account.

Connected research

Put this business in context.

Compare this company with peers, find it in your funds and follow its financial history with your connected AI:

  • “How do Owlet, Inc. and its peers compare on margins and cash generation over ten years?”
  • “Where did five years of Owlet, Inc.'s earnings go — cash, debt, buybacks, reinvestment?”
  • “What changed in Owlet, Inc.'s last four quarterly filings that the numbers alone won't show?”
See how it works →All research tools with a subscription. Use your own AI account.